NPC1L1 and hyperlipidemia: Postprandial hyperlipidemia was attenuated by pemafibrate via inhibition of intestinal cholesterol transporter NPC1L1 mRNA expression in small intestinal mucosa in mice fed a high-fat diet [39,40].